MMP2 and breast carcinoma: Functionally, chondroitin polymerizing factor acts as an oncogene that promotes breast carcinoma cell progression by facilitating proliferation, invasion and migration, as well as by elevating the expression of matrix metallopeptidase 2 and epithelial–mesenchymal transition‐related markers.